Multicenter Study of Cultured Autologous Oral Mucosal Epithelial Cell-Sheet (CAOMECS) Transplantation to Patients With Total Limbal Stem Cell Deficiency
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2019
Price : $35 *
At a glance
- Drugs Mucosal-derived epithelial cell therapy (Primary)
- Indications Limbal stem cell deficiency
- Focus Therapeutic Use
- Sponsors CellSeed
- 02 Feb 2019 This trial has been discontinued in UK - MHRA (End date:2014-09-08) as per European Clinical Trials Database record.
- 19 Apr 2017 This trial has been discontinued in Austria (End date:2014-08-08) as per European Clinical Trials Database record.
- 24 Mar 2015 Status changed from not yet recruiting to withdrawn prior to enrolment, as reported by ClinicalTrials.gov.